Considering the distinct function of TIGIT+Tregs in favoring Th2 immunity4,5,26, and that COVID-19 patients in ICU present signs of Th2-biased immunity27,28, we speculate that worse COVID-19 outcomes could be associated with impaired microbicidal immunity due to TIGIT+Tregs expansion. The gene discussed is TIGIT; the disease is COVID-19.